BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30028006)

  • 1. Strategies to Reduce Solute Carrier-Mediated Toxicity.
    Hu S; Sprowl JA
    Clin Pharmacol Ther; 2018 Nov; 104(5):799-802. PubMed ID: 30028006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
    Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
    Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
    Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
    Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
    Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.
    Zamek-Gliszczynski MJ; Taub ME; Chothe PP; Chu X; Giacomini KM; Kim RB; Ray AS; Stocker SL; Unadkat JD; Wittwer MB; Xia C; Yee SW; Zhang L; Zhang Y;
    Clin Pharmacol Ther; 2018 Nov; 104(5):890-899. PubMed ID: 30091177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Drug Transporters in Organ Toxicity: The Fundamental Basis of Drug Discovery and Development.
    Cheng Y; El-Kattan A; Zhang Y; Ray AS; Lai Y
    Chem Res Toxicol; 2016 Apr; 29(4):545-63. PubMed ID: 26889774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters and drug-drug interactions: important determinants of drug disposition and effects.
    König J; Müller F; Fromm MF
    Pharmacol Rev; 2013 Jul; 65(3):944-66. PubMed ID: 23686349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Transporter Consortium: Summarizing Advances in the Role of Transporters in Drug Development.
    Giacomini KM; Galetin A; Huang SM
    Clin Pharmacol Ther; 2018 Nov; 104(5):766-771. PubMed ID: 30137696
    [No Abstract]   [Full Text] [Related]  

  • 10. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
    Yang X; Han L
    Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.
    Momper JD; Tsunoda SM; Ma JD
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S82-98. PubMed ID: 27385182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in the design and development of transport inhibitors as adjuncts to drug therapy.
    Dantzig AH; de Alwis DP; Burgess M
    Adv Drug Deliv Rev; 2003 Jan; 55(1):133-50. PubMed ID: 12535578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hepatic transporters in drug elimination.
    Funk C
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue.
    Brück S; Strohmeier J; Busch D; Drozdzik M; Oswald S
    Biopharm Drug Dispos; 2017 Mar; 38(2):115-126. PubMed ID: 27516347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of Sutherlandia frutescens for herb-drug interaction.
    Fasinu PS; Gutmann H; Schiller H; James AD; Bouic PJ; Rosenkranz B
    Drug Metab Dispos; 2013 Feb; 41(2):488-97. PubMed ID: 23209194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transporters in drug efficacy and toxicity.
    DeGorter MK; Xia CQ; Yang JJ; Kim RB
    Annu Rev Pharmacol Toxicol; 2012; 52():249-73. PubMed ID: 21942630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular drug distribution: mechanisms and roles in drug efficacy, toxicity, resistance, and targeted delivery.
    Li Q; Zhou T; Wu F; Li N; Wang R; Zhao Q; Ma YM; Zhang JQ; Ma BL
    Drug Metab Rev; 2018 Nov; 50(4):430-447. PubMed ID: 30270675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond drug-drug interactions: effects of transporter inhibition on endobiotics, nutrients and toxins.
    Lepist EI; Ray AS
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1075-1087. PubMed ID: 28847160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics and systems biology of membrane transporters.
    Yan Q
    Mol Biotechnol; 2005 Jan; 29(1):75-88. PubMed ID: 15668521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.